VeriSIM Life
San Francisco, CA · United States
Specialization: AI-driven translational biosimulation
Key Differentiator
Its BIOiSIM platform produces a Translational Index score that predicts how a drug will perform in patients.
Core Services
BIOiSIM translational modelling; Drug-drug interaction prediction; Safety and toxicity profiling; Efficacy prediction; Formulation modelling; Drug repurposing
Capabilities
Market Intelligence
Founded in 2017 by Jo Varshney. It signed a Material Transfer Agreement with the FDA's National Center for Toxicological Research and runs PulmoSIM Therapeutics as a wholly owned brand.
Website
https://www.verisimlife.comSimilar Companies
Simulations Plus
Lancaster, CA · ADMET / PBPK Software
NASDAQ: SLP; only independent publicly-traded biosimulation company; GastroPlus = gold standard for oral absorption prediction; expanded into AI-driven training (2024-2025)
Metrum Research Group
Boston, MA · Pharmacometrics and modelling and simulation
Pairs modelling and simulation services with its own Metworx cloud platform for quantitative scientists.
Rosa & Co.
San Carlos, CA · Quantitative systems pharmacology (PhysioPD) modelling
Builds custom PhysioPD research platforms for clients without licensing fees.
A2-Ai
Ann Arbor, MI · Clinical pharmacology and pharmacometrics consulting
Combines clinical pharmacology consulting with its own analytics software, including A2-Ai Cloud, PRISM and Sage AI.
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.